Option Care Health (NASDAQ:OPCH) Releases Earnings Results, Hits Expectations

Option Care Health (NASDAQ:OPCH) posted its quarterly earnings results on Wednesday. The company reported $0.49 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.49, FiscalAI reports. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the previous year, the business earned $0.45 earnings per share. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded down $0.04 during midday trading on Wednesday, hitting $31.73. 2,114,915 shares of the stock were exchanged, compared to its average volume of 2,976,492. Option Care Health has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The company has a 50 day moving average price of $26.83 and a 200-day moving average price of $26.44. The stock has a market cap of $4.75 billion, a P/E ratio of 23.85, a PEG ratio of 1.93 and a beta of 0.47.

Analyst Ratings Changes

A number of equities research analysts have commented on OPCH shares. William Blair downgraded Option Care Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, October 6th. Deutsche Bank Aktiengesellschaft cut shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price target for the stock from $26.00 to $24.00 in a research note on Thursday, July 30th. Citizens Jmp downgraded shares of Option Care Health from a “market outperform” rating to a “hold” rating in a report on Wednesday, October 7th. Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Finally, JPMorgan Chase & Co. downgraded shares of Option Care Health from an “overweight” rating to a “neutral” rating and set a $33.00 price objective on the stock. in a report on Wednesday, October 7th. Two research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $29.48.

Option Care Health News Roundup

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Q3 revenue rose 4.1% year over year to $1.49 billion, topping estimates of about $1.48 billion. Adjusted earnings were $0.49 per share, matching the $0.49 consensus cited by several reports and beating Zacks’ $0.48 estimate; EPS was up from $0.45 a year earlier. Option Care Health Q3 results Zacks Q3 earnings report
• Neutral Sentiment: Two law firms announced investigations related to the fairness of a merger involving OPCH. The notices provide no specific findings or details in the supplied reports, so the implications for shareholders—and any potential effect on the stock—are unclear. Merger investigation notice

Option Care Health Company Profile

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.